http://www.mail.com/companies/42116-novartis-ag.html Mail.com - the best personalized free web-based Email en en http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png http://www.mail.com/companies/42116-novartis-ag.html http://www.mail.com/business/economy/2097592-actavis-buying-warner-chilcott-85b-deal.html NEW YORK (AP) — Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market. The announcement Monday comes after the companies said earlier this month that they were in talks about a possible pairing of one of the world's largest generic drugmak... Mon, 20 May 2013 22:36:45 GMT http://www.mail.com/business/economy/2097592-actavis-buying-warner-chilcott-85b-deal.html 2013-05-20T22:36:45Z http://www.mail.com/business/economy/2053288-pfizer-1q-profit-up-drugmaker-cuts-outlook.html Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's expectations, and the company lowered its profit and sales forecasts for the year, blaming sudden worsening of currency exchange rates. Pfizer is struggl... Tue, 30 Apr 2013 21:25:59 GMT http://www.mail.com/business/economy/2053288-pfizer-1q-profit-up-drugmaker-cuts-outlook.html 2013-04-30T21:25:59Z http://www.mail.com/business/economy/2041282-novartis-posts-profit-gain-thanks-to-drugs.html BASEL, Switzerland (AP) — Swiss pharmaceutical company Novartis AG reported a 6.7 percent increase in profit for the first quarter Wednesday, boosted by new products and emerging markets. Novartis says its net profit rose to $2.42 billion from $2.27 billion in the same period last year despite declining sales of its blockbuster heart drug Diovan, which lo... Wed, 24 Apr 2013 19:29:11 GMT http://www.mail.com/business/economy/2041282-novartis-posts-profit-gain-thanks-to-drugs.html 2013-04-24T19:29:11Z http://www.mail.com/scitech/health/1991800-indias-rejection-drug-patent-reverberate.html The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. The ruling, which was handed down on Monday, signals the latest shift in the world of drug development in emerging markets such as India and Brazil, where drugmakers have been lookin... Tue, 02 Apr 2013 01:06:08 GMT http://www.mail.com/scitech/health/1991800-indias-rejection-drug-patent-reverberate.html 2013-04-02T01:06:08Z http://www.mail.com/scitech/health/1990134-drug-maker-novartis-loses-india-patent-battle.html NEW DELHI (AP) — India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines. Novartis had argued that it needed a patent to protect its inve... Mon, 01 Apr 2013 13:27:28 GMT http://www.mail.com/scitech/health/1990134-drug-maker-novartis-loses-india-patent-battle.html 2013-04-01T13:27:28Z http://www.mail.com/scitech/health/1989096-indias-top-court-to-deliver-novartis-judgment.html NEW DELHI (AP) — India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies that say they should be allowed to continue producing cheaper generic versions of many lifesaving medicines. A decision in the seve... Sun, 31 Mar 2013 07:46:17 GMT http://www.mail.com/scitech/health/1989096-indias-top-court-to-deliver-novartis-judgment.html 2013-03-31T07:46:17Z http://www.mail.com/scitech/health/1931852-india-rejects-bayer-plea-cheap-cancer-drug.html NEW DELHI (AP) — India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive lifesaving medicines to the poor. Last year, India's patent office allowed local drug manufacturer Natco Pharma Ltd. t... Tue, 05 Mar 2013 16:17:17 GMT http://www.mail.com/scitech/health/1931852-india-rejects-bayer-plea-cheap-cancer-drug.html 2013-03-05T16:17:17Z http://www.mail.com/business/economy/1928122-swiss-voters-approve-tough-limits-bosses-pay.html BERLIN (AP) — Swiss voters voiced their anger at perceived corporate greed Sunday by approving a plan to boost shareholders' say on executive pay. Some 67.9 percent of voters backed the "Rip-Off Initiative," with 32.1 percent against, according to the official count broadcast by Swiss public television station SRF. The outcome of the referendum was consid... Sun, 03 Mar 2013 16:37:47 GMT http://www.mail.com/business/economy/1928122-swiss-voters-approve-tough-limits-bosses-pay.html 2013-03-03T16:37:47Z http://www.mail.com/business/economy/1900360-novartis-chairman-foregoes-78-payout.html BERLIN (AP) — Swiss drugmaker Novartis AG has agreed with its outgoing chairman to scrap plans for a farewell non-compete deal that could have netted him up to 72 million francs ($78 million). The announcement followed criticism from some of the Basel-based company's shareholders and Swiss politicians. Daniel Vasella, 59, who is retiring later this month,... Tue, 19 Feb 2013 19:45:57 GMT http://www.mail.com/business/economy/1900360-novartis-chairman-foregoes-78-payout.html 2013-02-19T19:45:57Z http://www.mail.com/business/economy/1839886-novartis-q4-net-profit-rebounds-to-21-billion.html BERLIN (AP) — Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year. Net profit during the final quarter of last year rose 72 percent from the $1.21 billion net profit posted in the final three months of 2011, w... Wed, 23 Jan 2013 09:27:00 GMT http://www.mail.com/business/economy/1839886-novartis-q4-net-profit-rebounds-to-21-billion.html 2013-01-23T09:27:00Z http://www.mail.com/scitech/health/1799084-indian-court-to-rule-generic-drug-industry.html NEW DELHI (AP) — From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines. The case — involving Swiss dru... Fri, 04 Jan 2013 11:48:00 GMT http://www.mail.com/scitech/health/1799084-indian-court-to-rule-generic-drug-industry.html 2013-01-04T11:48:00Z http://www.mail.com/business/economy/1733992-jj-board-picks-ceo-to-replace-retiring-chairman.html NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson Chairman Bill Weldon will step down from that post in late December and the world's biggest maker of health products has picked new CEO Alex Gorsky to replace him. The New Brunswick, N.J., company had named Gorsky, 52, as CEO earlier this year, replacing Weldon. J&J said Friday that Weldon will step down Dec. 2... Fri, 30 Nov 2012 17:23:00 GMT http://www.mail.com/business/economy/1733992-jj-board-picks-ceo-to-replace-retiring-chairman.html 2012-11-30T17:23:00Z